approval · primary record
ANSUVIMAB-ZYKL
FDA · BLA · 2026-02-18
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2026-02-18 |
| Brand | EBANGA |
| Sponsor | RIDGEBACK BIOTHERAPEUTICS |
| Route | IV (INFUSION) |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:11.395Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:ANSUVIMAB-ZYKL:2026-02-18
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.